Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification.
Etra A, Gergoudis S, Morales G, Spyrou N, Shah J, Kowalyk S, Ayuk F, Baez J, Chanswangphuwana C, Chen YB, Choe H, DeFilipp Z, Gandhi I, Hexner E, Hogan WJ, Holler E, Kapoor U, Kitko CL, Kraus S, Lin JY, Al Malki M, Merli P, Pawarode A, Pulsipher MA, Qayed M, Reshef R, Rösler W, Schechter T, Van Hyfte G, Weber D, Wölfl M, Young R, Özbek U, Ferrara JLM, Levine JE. Etra A, et al. Among authors: pulsipher ma. Blood Adv. 2022 Jun 28;6(12):3707-3715. doi: 10.1182/bloodadvances.2022007296. Blood Adv. 2022. PMID: 35443021 Free PMC article.
Use of G-CSF in matched sibling donor pediatric allogeneic transplantation: a consensus statement from the Children's Oncology Group (COG) Transplant Discipline Committee and Pediatric Blood and Marrow Transplant Consortium (PBMTC) Executive Committee.
Grupp SA, Frangoul H, Wall D, Pulsipher MA, Levine JE, Schultz KR. Grupp SA, et al. Among authors: pulsipher ma. Pediatr Blood Cancer. 2006 Apr;46(4):414-21. doi: 10.1002/pbc.20800. Pediatr Blood Cancer. 2006. PMID: 16463346 Review.
A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study.
Frangoul H, Nemecek ER, Billheimer D, Pulsipher MA, Khan S, Woolfrey A, Manes B, Cole C, Walters MC, Ayas M, Ravindranath Y, Levine JE, Grupp SA. Frangoul H, et al. Among authors: pulsipher ma. Blood. 2007 Dec 15;110(13):4584-7. doi: 10.1182/blood-2007-07-101071. Epub 2007 Sep 7. Blood. 2007. PMID: 17827386 Free article. Clinical Trial.
Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.
Rotta M, Storer BE, Sahebi F, Shizuru JA, Bruno B, Lange T, Agura ED, McSweeney PA, Pulsipher MA, Hari P, Maziarz RT, Chauncey TR, Appelbaum FR, Sorror ML, Bensinger W, Sandmaier BM, Storb RF, Maloney DG. Rotta M, et al. Among authors: pulsipher ma. Blood. 2009 Apr 2;113(14):3383-91. doi: 10.1182/blood-2008-07-170746. Epub 2008 Nov 17. Blood. 2009. PMID: 19015394 Free PMC article. Clinical Trial.
Impact of conditioning regimen in allogeneic hematopoetic stem cell transplantation for children with acute myelogenous leukemia beyond first complete remission: a pediatric blood and marrow transplant consortium (PBMTC) study.
Sisler IY, Koehler E, Koyama T, Domm JA, Ryan R, Levine JE, Pulsipher MA, Haut PR, Schultz KR, Taylor DS, Frangoul HA. Sisler IY, et al. Among authors: pulsipher ma. Biol Blood Marrow Transplant. 2009 Dec;15(12):1620-7. doi: 10.1016/j.bbmt.2009.08.014. Epub 2009 Oct 1. Biol Blood Marrow Transplant. 2009. PMID: 19896086 Free article.
Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remission.
Nemecek ER, Ellis K, He W, Bunin NJ, Bajwa RS, Cheerva A, Cairo MS, Dvorak C, Duval M, Davies S, Eapen M, Gross TG, Hussein AA, MacMillan ML, Mehta PA, Pulsipher MA, Seber A, Woolfrey AE, Frangoul HA, Carpenter PA. Nemecek ER, et al. Among authors: pulsipher ma. Biol Blood Marrow Transplant. 2011 Dec;17(12):1833-40. doi: 10.1016/j.bbmt.2011.05.014. Epub 2011 May 27. Biol Blood Marrow Transplant. 2011. PMID: 21683798 Free PMC article.
National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage and dysfunction.
Nieder ML, McDonald GB, Kida A, Hingorani S, Armenian SH, Cooke KR, Pulsipher MA, Baker KS. Nieder ML, et al. Among authors: pulsipher ma. Biol Blood Marrow Transplant. 2011 Nov;17(11):1573-84. doi: 10.1016/j.bbmt.2011.09.013. Epub 2011 Oct 1. Biol Blood Marrow Transplant. 2011. PMID: 21963877 Free PMC article.
Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).
Kamani NR, Walters MC, Carter S, Aquino V, Brochstein JA, Chaudhury S, Eapen M, Freed BM, Grimley M, Levine JE, Logan B, Moore T, Panepinto J, Parikh S, Pulsipher MA, Sande J, Schultz KR, Spellman S, Shenoy S. Kamani NR, et al. Among authors: pulsipher ma. Biol Blood Marrow Transplant. 2012 Aug;18(8):1265-72. doi: 10.1016/j.bbmt.2012.01.019. Epub 2012 Feb 16. Biol Blood Marrow Transplant. 2012. PMID: 22343376 Free PMC article. Clinical Trial.
Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era.
Warlick E, Ahn KW, Pedersen TL, Artz A, de Lima M, Pulsipher M, Akpek G, Aljurf M, Cahn JY, Cairo M, Chen YB, Cooper B, Deol A, Giralt S, Gupta V, Khoury HJ, Kohrt H, Lazarus HM, Lewis I, Olsson R, Pidala J, Savani BN, Seftel M, Socié G, Tallman M, Ustun C, Vij R, Vindeløv L, Weisdorf D. Warlick E, et al. Blood. 2012 Apr 26;119(17):4083-90. doi: 10.1182/blood-2012-02-409763. Epub 2012 Mar 9. Blood. 2012. PMID: 22408257 Free PMC article.
292 results